Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB093 (glibenclamide) for severe cerebral edema following large hemispheric infarction
2017-004854-41Phase 3Unknown
- Sponsor
- Biogen
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cerebral edema and large hemispheric infarction (LHI) comparing BIIB093 arm with Placebo arm (2 arms). Status: unknown.
02
Drugs
glibenclamide
03
Conditions
cerebral edemalarge hemispheric infarction (LHI)
Beyond the preview
Go deeper on 2017-004854-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004854-41.